On Friday, Lilly(Eli) & Co (NYSE: LLY) opened lower -0.25% from the last session, before settling in for the closing price of $749.92. Price fluctuations for LLY have ranged from $561.65 to $972.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 9.91%. Company’s average yearly earnings per share was noted 109.82% at the time writing. With a float of $850.67 million, this company’s outstanding shares have now reached $949.38 million.
Considering the fact that the conglomerate employs 43000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 81.56%, operating margin of 35.33%, and the pretax margin is 24.84%.
Lilly(Eli) & Co (LLY) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Lilly(Eli) & Co is 10.39%, while institutional ownership is 72.74%. The most recent insider transaction that took place on Nov 08 ’24, was worth 723,042. Before that another transaction happened on Nov 08 ’24, when Company’s SVP, Finance, & CAO sold 900 for $803.38, making the entire transaction worth $723,042. This insider now owns 5,480 shares in total.
Lilly(Eli) & Co (LLY) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted 2.49 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 2.37) by 0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of 5.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 109.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.00% during the next five years compared to 13.74% growth over the previous five years of trading.
Lilly(Eli) & Co (NYSE: LLY) Trading Performance Indicators
Check out the current performance indicators for Lilly(Eli) & Co (LLY). In the past quarter, the stock posted a quick ratio of 0.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.33. Likewise, its price to free cash flow for the trailing twelve months is 505.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 9.14, a number that is poised to hit 5.47 in the next quarter and is forecasted to reach 22.52 in one year’s time.
Technical Analysis of Lilly(Eli) & Co (LLY)
Compared to the last year’s volume of 3.19 million, its volume of 5.66 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 29.94%. Additionally, its Average True Range was 25.46.
During the past 100 days, Lilly(Eli) & Co’s (LLY) raw stochastic average was set at 14.02%, which indicates a significant decrease from 26.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.78% in the past 14 days, which was higher than the 35.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $864.95, while its 200-day Moving Average is $835.83. Nevertheless, the first resistance level for the watch stands at $757.83 in the near term. At $767.66, the stock is likely to face the second major resistance level. The third major resistance level sits at $774.03. If the price goes on to break the first support level at $741.63, it is likely to go to the next support level at $735.26. Should the price break the second support level, the third support level stands at $725.44.
Lilly(Eli) & Co (NYSE: LLY) Key Stats
There are currently 949,316K shares outstanding in the company with a market cap of 708.29 billion. Presently, the company’s annual sales total 34,124 M according to its annual income of 5,240 M. Last quarter, the company’s sales amounted to 11,439 M and its income totaled 970,300 K.
